Is a cell saver necessary in off-pump coronary artery bypass surgery?

Asian Cardiovascular and Thoracic Annals

Volumn 20, Issue 5, 2012, Pages 539-543

  Tan, Nguyen Luong ^a   Corbineau, Hervé ^b   Phu, Bui Duc ^a   Verhoye, Jean Philippe ^b  

^a Hue Central Hospital   (Viet Nam)

^b PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

Autologous; Blood loss; Blood transfusion; Coronary artery bypass; Erythrocyte transfusion; Risk factors; Surgical

Indexed keywords

HEMOGLOBIN; BIOLOGICAL MARKER;

ADULT; AGED; ARTERY LESION; ARTICLE; BLOOD AUTOTRANSFUSION; CARDIOVASCULAR SURGICAL EQUIPMENT; CELL SAVER; CORONARY ARTERY BYPASS GRAFT; ERYTHROCYTE TRANSFUSION; ERYTHROCYTE VOLUME; FEMALE; HEART MUSCLE REVASCULARIZATION; HEMOGLOBIN BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; INTERNAL MAMMARY ARTERY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OFF PUMP CORONARY SURGERY; POSTOPERATIVE CARE; PREOPERATIVE PERIOD; PROSPECTIVE STUDY; RISK FACTOR; SEX; SURGICAL PATIENT; BLEEDING; BLOOD; BLOOD SALVAGE; CHI SQUARE DISTRIBUTION; CORONARY ARTERY DISEASE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTOPERATIVE HEMORRHAGE; RISK; SEX DIFFERENCE; STATISTICAL MODEL; TIME; TREATMENT OUTCOME;

AGED; BIOLOGICAL MARKERS; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION, AUTOLOGOUS; CHI-SQUARE DISTRIBUTION; CORONARY ARTERY BYPASS, OFF-PUMP; CORONARY ARTERY DISEASE; FEMALE; HEMOGLOBINS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; OPERATIVE BLOOD SALVAGE; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84875867372     PISSN: 02184923     EISSN: 18165370     Source Type: Journal    
DOI: 10.1177/0218492312439479     Document Type: Article

References (18)

1. Kuss O, von Salviati B and Börgermann J. Off-pump versus on-pump coronary artery bypass grafting: a systematic review and meta-analysis of propensity score analyses. J Thorac Cardiovasc Surg 2010; 140: 829-835.
2. Kerendi F, Morris CD and Puskas JD. Off-pump coronary bypass surgery for high-risk patients: only in expert centers? Curr Opin Cardiol 2008; 23: 573-578.
3. Corbineau H, Verhoye JP, Langanay T, Ménestret P and Leguerrier A. Feasibility of the utilisation of the right internal thoracic artery in the transverse sinus in off pump coronary revascularisation: early angiographic results. Eur J Cardiothorac Surg 2001; 20: 918-922.
4. Shroyer AL, Grover FL, Hattler B, Collins JF, McDonald GO and Kozora E. On-pump versus off-pump coronaryartery bypass surgery. N Engl J Med 2009; 361: 1827-1837.
5. DeFoe GR, Ross CS, Olmstead EM, Surgenor SD, Fillinger MP, Groom RC, et al. Lowest hematocrit on bypass and adverse outcomes associated with coronary artery bypass grafting. Northern New England Cardiovascular Disease Study Group. Ann Thorac Surg 2001; 71: 769-776.
6. Karkouti K, Djaiani G, Borger MA, Beattie WS, Fedorko L, Wijeysundera D, et al. Low hematocrit during cardiopulmonary bypass is associated with increased risk of perioperative stroke in cardiac surgery. Ann Thorac Surg 2005; 80: 1381-1387.
7. Karkouti K, Beattie WS, Wijeysundera DN, Rao V, Chan C, Dattilo KM, et al. Hemodilution during cardiopulmonary bypass is an independent risk factor for acute renal failure in adult cardiac surgery. J Thorac Cardiovasc Surg 2005; 129: 391-400.
8. Habib RH, Zacharias A, Schwann TA, Riordan CJ, Engoren M, Durham SJ, et al. Role of hemodilutional anemia and transfusion during cardiopulmonary bypass in renal injury after coronary revascularization: implications on operative outcome. Crit Care Med 2005; 33: 1749-1756.
9. Koch CG, Khandwala F, Li L, Estafanous FG, Loop FD and Blackstone EH. Persistent effect of red cell transfusion on health-related quality of life after cardiac surgery. Ann Thorac Surg 2006; 82: 13-20.
10. Koch CG, Li L, Duncan AI, Mihaljevic T, Cosgrove DM, Loop FD, et al. Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med 2006; 34: 1608-1616.
11. Koch CG, Li L, Duncan AI, Mihaljevic T, Loop FD, Starr NJ, et al. Transfusion in coronary artery bypass grafting is associated with reduced long-term survival. Ann Thorac Surg 2006; 81: 1650-1657.
12. Koch CG, Li L, Van Wagoner DR, Duncan AI, Gillinov AM and Blackstone EH. Red cell transfusion is associated with an increased risk for postoperative atrial fibrillation. Ann Thorac Surg 2006; 82: 1747-1756.
13. Engoren MC, Habib RH, Zacharias A, Schwann TA, Riordan CJ and Durham SJ. Effect of blood transfusion on long-term survival after cardiac operation. Ann Thorac Surg 2002; 74: 1180-1186.
14. Murphy GJ, Reeves BC, Rogers CA, Rizvi SI, Culliford L and Angelini GD. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 2007; 116: 2544-2552.
15. Niranjan G, Asimakopoulos G, Karagounis A, Cockerill G, Thompson M and Chandrasekaran V. Effects of cell saver autologous blood transfusion on blood loss and homologous blood transfusion requirements in patients undergoing cardiac surgery on- versus off-cardiopulmonary bypass: a randomised trial. Eur J Cardiothorac Surg 2006; 30: 271-277.
16. Damgaard S and Steinbrüchel DA. Autotransfusion with cell saver for off-pump coronary artery bypass surgery: a randomized trial. Scand Cardiovasc J 2006; 40: 194-198.
17. Goel P, Pannu H, Mohan D and Arora R. Efficacy of cell saver in reducing homologous blood transfusions during OPCAB surgery: a prospective randomized trial. Transfus Med 2007; 17: 285-289.
18. Dial S, Delabays E, Albert M, Gonzalez A, Camarda J, Law A, et al. Hemodilution and surgical hemostasis contribute significantly to transfusion requirements in patients undergoing coronary artery bypass. J Thorac Cardiovasc Surg 2005; 130: 654-661.